Cis-diamminedichloroplatinum(II) chemotherapy in advanced pancreatic carcinoma |
| |
| Authors: | H Tajiri M Yoshimori A Hijikata K Nakamura H Ohkura N Okazaki |
| |
| Affiliation: | Dept. of Internal Medicine, National Cancer Center Hospital. |
| |
| Abstract: | The effect of cis-diamminedichloro platinum (II) (CDDP) was evaluated in 14 patients with advanced pancreatic carcinoma. Prior chemotherapy was done in 7 cases and the remaining 7 were fresh cases. The drug was given at a dose of 80 mg/m2 I.V. every 3 weeks, with hydration and mannitol diuresis. Four cases out of 14 showed no change, while the remaining 10 cases showed progressive disease. The response rate was 0%. Most of the patients who showed myelosuppression had received prior chemotherapy. Non-hematologic toxicity occurred in 9 patients (64%) and consisted of nausea in 9, vomiting in 7 and anorexia in 9. Values of serum creatinine and BUN were transiently elevated. |
| |
| Keywords: | |
|
|
